Xintian Pharmaceutical: Legal Opinions of Beijing Deheng Law Firm on matters relating to the repurchase and cancellation of some restricted stocks in the Company's 2021 Restricted Stock Incentive Plan

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.